Glaxosmithkline | GSK - Assets

Stock Price
50.17
Daily Change
-0.73 -1.43%
Monthly
-0.65%
Yearly
33.29%
Q2 Forecast
48.78

Glaxosmithkline reported GBP82.34B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
AbbVie USD 136.46B 2.5B Mar/2026
Amgen USD 92.5B 1.92B Mar/2026
AstraZeneca USD 114.02B 59M Mar/2026
Aurora Cannabis CAD 775.29M 18.43M Dec/2025
Bausch Health Companies USD 24.5B 1.87B Mar/2026
Bristol-Myers Squibb USD 86.48B 3.56B Mar/2026
Canopy Growth CAD 1.11B 36.35M Dec/2025
Corcept Therapeutics USD 814.88M 21.77M Mar/2026
Drreddys Laboratories INR 6.26B 161.9M Dec/2025
Eli Lilly USD 116.58B 4.1B Mar/2026
GlaxoSmithKline GBP 62.87B 1.75B Mar/2026
Glaxosmithkline GBP 82.34B 102.25M Dec/2025
J&J USD 200.89B 1.68B Mar/2026
Merck USD 128.68B 8.18B Mar/2026
Novartis USD 118.53B 7.58B Mar/2026
Pacira USD 1.21B 56.38M Mar/2026
Perrigo USD 7.98B 551.9M Mar/2026
Pfizer USD 207.62B 542M Mar/2026
Phibro Animal Health USD 1.45B 39.56M Mar/2026
Prestige Brands USD 3.49B 430K Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 128.02B 1.22B Mar/2026
Supernus Pharmaceuticals USD 1.5B 48.08M Mar/2026
Takeda JPY 15.45T 44.34B Mar/2026
Teva Pharmaceutical Industries USD 40.04B 708M Mar/2026
Zoetis USD 15.15B 313M Mar/2026